FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall

FDA provides update on ongoing investigation into ARB drugs; new losartan recall announced

Source: Food and Drug Administration - April 27, 2019 Category: American Health Authors: FDA Source Type: news